Last: | $41.54 |
---|---|
Change Percent: | -0.07% |
Open: | $41.64 |
Close: | $41.54 |
High: | $41.925 |
Low: | $41.24 |
Volume: | 2,691,674 |
Last Trade Date Time: | 03/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$41.54 | $41.64 | $41.54 | $41.925 | $41.24 | 2,691,674 | 03-18-2024 |
$41.61 | $41.31 | $41.61 | $41.91 | $41.3 | 5,489,356 | 03-15-2024 |
$42.02 | $42.4 | $42.02 | $42.64 | $41.67 | 3,795,705 | 03-14-2024 |
$42.68 | $42.96 | $42.68 | $43.35 | $42.37 | 3,851,996 | 03-13-2024 |
$42.89 | $43.26 | $42.89 | $43.37 | $42.82 | 3,648,644 | 03-12-2024 |
$43.48 | $43.65 | $43.48 | $43.97 | $43.375 | 1,973,234 | 03-11-2024 |
$43.77 | $43.38 | $43.77 | $44.005 | $43.29 | 2,816,447 | 03-08-2024 |
$43.49 | $43.3 | $43.49 | $43.68 | $43.04 | 3,949,699 | 03-07-2024 |
$42.99 | $42.45 | $42.99 | $43.02 | $42.07 | 3,445,855 | 03-06-2024 |
$42.41 | $43.56 | $42.41 | $43.93 | $42.24 | 6,879,222 | 03-05-2024 |
$42.5 | $41 | $42.5 | $42.64 | $40.84 | 6,431,116 | 03-04-2024 |
$41.01 | $40.92 | $41.01 | $41.205 | $40.27 | 2,825,026 | 03-01-2024 |
$40.92 | $41.4 | $40.92 | $41.4 | $40.61 | 5,249,105 | 02-29-2024 |
$41.56 | $41.64 | $41.56 | $41.6496 | $41.16 | 2,792,145 | 02-28-2024 |
$41.85 | $41.92 | $41.85 | $42.18 | $41.56 | 2,137,566 | 02-27-2024 |
$42 | $42.44 | $42 | $42.54 | $41.81 | 2,346,230 | 02-26-2024 |
$42.55 | $41.99 | $42.55 | $42.87 | $41.62 | 3,262,594 | 02-23-2024 |
$42.01 | $42.07 | $42.01 | $42.13 | $41.245 | 4,115,894 | 02-22-2024 |
$42.23 | $41.67 | $42.23 | $42.28 | $41.37 | 3,910,459 | 02-21-2024 |
$41.77 | $41.16 | $41.77 | $42.05 | $41.04 | 5,002,790 | 02-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Baxter International Inc. Company Name:
BAX Stock Symbol:
NYSE Market:
Baxter International Inc. Website:
Tuesday, Novo Nordisk A/S (NYSE:NVO) released the headline results from the kidney outcomes trial, FLOW. The trial achieved its primary e...
Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Raymond James 45th Annual Institutional Investors Conference on Monday, March 4, 2024. Joel Grade, Baxter’s chief financial officer, is scheduled to present at 4:00 p.m. Eastern Time. The live webcast of...
TORONTO, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, is pleased to announce an extension to its supply and distribution...